Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Dingemans, Anne Marie C ^a   van den Boogaart, Vivian ^a   Vosse, Bettine A ^a   van Suylen, Robert Jan ^a   Griffioen, Arjan W ^a,b   Thijssen, Victor L ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA1 INTEGRIN; ALPHA11 INTEGRIN; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; ALPHA7 INTEGRIN; BETA INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA4 INTEGRIN; BETA5 INTEGRIN; BETA6 INTEGRIN; BETA8 INTEGRIN; CD51 ANTIGEN; COMPLEMENTARY DNA; MESSENGER RNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; FROZEN SECTION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SURVIVAL TIME; BIOSYNTHESIS; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD29; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTEGRIN ALPHAV; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77953548261     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-152     Document Type: Article

References (26)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:581-592. 10.1093/annonc/mdl498, 17287242.
2. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002, 64:681-708. 10.1146/annurev.physiol.64.081501.155828, 11826285.
3. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26:3552-3559. 10.1200/JCO.2007.13.9030, 18506026.
4. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987, 48:549-554. 10.1016/0092-8674(87)90233-9, 3028640.
5. Engers R, Gabbert HE. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000, 126:682-692. 10.1007/s004320000148, 11153140.
6. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2:91-100. 10.1038/nrc727, 12635172.
7. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826. 10.1038/nrm1490, 15459662.
8. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000, 6:96-101.
9. Adachi M, Taki T, Huang C, Higashiyama M, Doi O, Tsuji T, Miyake M. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 1998, 16:1060-1067.
10. Boelens MC, van den Berg A, Vogelzang I, Wesseling J, Postma DS, Timens W, Groen HJ. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. J Clin Pathol 2007, 60:608-614. 10.1136/jcp.2005.031443, 1955047, 16489176.
11. Han JY, Kim HS, Lee SH, Park WS, Lee JY, Yoo NJ. Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis. Lung Cancer 2003, 41:65-70. 10.1016/S0169-5002(03)00146-6, 12826314.
12. Smythe WR, Wasfi D, Bavaria JE, Albelda SM, Kaiser LR. Loss of alpha-v integrin expression and recurrence in node-negative lung carcinoma. Ann Thorac Surg 1997, 64:949-953. 10.1016/S0003-4975(97)00851-5, 9354507.
13. Gogali A, Charalabopoulos K, Constantopoulos S. Integrin receptors in primary lung cancer. Exp Oncol 2004, 26:106-110.
14. Elayadi AN, Samli KN, Prudkin L, Liu YH, Bian A, Xie XJ, Roth JA, McGuire MJ, Brown KC. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer. Cancer Res 2007, 67:5889-5895. 10.1158/0008-5472.CAN-07-0245, 17575158.
15. Thijssen VL, Brandwijk RJ, Dings RP, Griffioen AW. Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp Cell Res 2004, 299:286-293. 10.1016/j.yexcr.2004.06.014, 15350528.
16. Guo L, Zhang F, Cai Y, Liu T. Expression profiling of integrins in lung cancer cells. Pathol Res Pract 2009, 205:847-853. 10.1016/j.prp.2009.07.005, 19674850.
17. Mette SA, Pilewski J, Buck CA, Albelda SM. Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am J Respir Cell Mol Biol 1993, 8:562-572.
18. Okamura M, Yamaji S, Nagashima Y, Nishikawa M, Yoshimoto N, Kido Y, Iemoto Y, Aoki I, Ishigatsubo Y. Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum Pathol 2007, 38:1081-1091. 10.1016/j.humpath.2007.01.003, 17442374.
19. Takenaka K, Shibuya M, Takeda Y, Hibino S, Gemma A, Ono Y, Kudoh S. Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line. Int J Oncol 2000, 17:1187-1194.
20. Damjanovich L, Albelda SM, Mette SA, Buck CA. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol 1992, 6:197-206.
21. Koukoulis GK, Warren WH, Virtanen I, Gould VE. Immunolocalization of integrins in the normal lung and in pulmonary carcinomas. Hum Pathol 1997, 28:1018-1025. 10.1016/S0046-8177(97)90054-X, 9308725.
22. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000, 355:479-485.
23. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992, 339:1453-1457. 10.1016/0140-6736(92)92039-I, 1376386.
24. Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Lett 2007, 247:1-25. 10.1016/j.canlet.2006.03.031, 16725254.
25. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009, 28:15-33. 10.1007/s10555-008-9169-0, 19169796.
26. Mercurio AM, Rabinovitz I, Shaw LM. The alpha 6 beta 4 integrin and epithelial cell migration. Curr Opin Cell Biol 2001, 13:541-545. 10.1016/S0955-0674(00)00249-0, 11544021.